.png)
Clinical Studies
SVG Pharma supports sponsor-led clinical studies across selected therapeutic areas within Australia's regulated research environment.
​
Information provided for professional and scientific context only. All studies are conducted in accordance with Australian regulatory and ethics requirements. Data ownership and rights of publication and further dissemination are retained by the respective data owners.
GENESIS STUDY
A Phase III clinical evaluation of cannabidiol for IBS-related abdominal pain
Study Phase & Design: Phase III, double-blind, randomised, placebo-controlled
Therapeutic Area: Gastroenterology
Investigational Product: Cannabidiol oral oil formulation
Study Sponsor / CRO: SVG Pharma
Principal Investigator: Dr Chris Schneider
Geography: Australia
Trial Registration: ACTRN12622001179729
Ethics Approval: Bellberry Limited – Human Research Ethics Committee
Study Status: Completed (January 2025)​
Outcomes
The study has been completed in accordance with the approved protocol and Good Clinical Practice (GCP) guidelines. A full clinical dataset has been generated, representing one of the few controlled clinical datasets globally investigating cannabidiol in this therapeutic area. Results are currently being prepared for publication in a peer-reviewed journal.
​​
Data Licensing
De-identified clinical trial data from this study is available for licensing. For enquiries, contact info@svgpharma.com.au.​​
Regulatory scheduling and product registration outcomes are separate from the completion and scientific validity of a clinical study. Study information is provided for professional and scientific context only and does not constitute medical advice, a recommendation, or promotion of any therapeutic product.
METRODORA STUDY
A Phase II investigation of a cannabinoid-based therapy for dysmenorrhea
Study Phase & Design: Phase II, double-blind, randomised comparison study
Therapeutic Area: Women's Health
Investigational Product: Cannabinoid-based therapeutic
Study Sponsor: NectarTek
Principal Investigator: Dr Chris Schneider
Geography: Tasmania and Victoria
Ethics Approval: In progress
Study Status: Ethics and regulatory approvals in progress​
Participant eligibility and recruitment will proceed strictly in accordance with approved ethics and site protocols.
​​​Study information is provided for professional and scientific context only and does not constitute medical advice, a recommendation, or promotion of any therapeutic product.
Sponsors & Collaborators
SVG Pharma collaborates with leading Australian sponsors and suppliers across our clinical programs.
